Brexit and the delay in the supply of medicines

Earlier this year, the Brexit Health Alliance published a paper calling on both the UK and EU to put patients first.

It warned that unless a deal can be reached, medicines and medical technologies could be delayed or, in extreme cases, become unavailable to patients.

The Alliance is concerned that if a decision can’t be reached regarding the future co-operation between the UK and the EU on the regulation and trade of medicines and medical devices that up to 120,000 prostate cancer patients throughout Europe could be affected.

Another area at risk is the future of research into new medicines and medical technologies. Without a plan in place, UK and EU patients could lose out on access to the best treatments and medical devices.

Are you concerned about the impact of Brexit? 
You can find below what the M3 Global Research community answered to this question.

Let us hear your opinion on this by signing up to receive the Monthly Pulse via email and to take part in paid medical studies.

 

Bullying, undermining and harassment at work

August’s Monthly Pulse question was about bullying, undermining and harassment at work. Around one in five doctors in the UK’s NHS say they have been bullied or harassed in the workplace, with the British Orthopaedic Trainee Association (BOTA) reporting that 73% trainees had witnessed bullying, undermining or harassment at work. Most incidents go unreported, often because staff are afraid to raise concerns or they believe nothing will happen. This situation seems to be a common issue worldwide.

BOTA‘s #HammerItOut campaign, which aims to highlight the issue, uses the following definitions: Undermining is behaviour that subverts, weakens or wears away confidenceBullying is behaviour that hurts or frightens someone who is less powerful, often forcing them to do something they do not want to do. Bullying and harassment means any unwanted behaviour that makes someone feel intimidated, humiliated or offended.

The question we delivered to our medical community in August was the following:

Have you ever experienced or witnessed bullying, undermining or harassment at work?

In Europe the analysis was conducted amongst 5,016 M3 members in the UK, France, Germany, Italy and Spain. 65% of the healthcare professional surveyed have experienced or witnessed bullying, undermining and harassment at work. Bulling and harassment was most prevalent in the UK and France at 78% and 73% respectively. On the other hand, Italy has the lowest incidence.

The cross-continental analysis shows that 73% of healthcare professionals surveyed in USA have witnessed the same situation. Bullying and harassment was most prevalent in Canada at 85% while Europe has the lowest incidence at 35%.

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to give your personal opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.

harassment at work

Monthly Pulse

 

Universal healthcare coverage

Universal healthcare coverage was the Monthly Pulse topic we sent out to our consumer panel members’ in August.

Healthcare reform has long since been a major policy area commanding attention in the United States and around the world. Crucial to the debate are the various plans that have been proposed to repeal and replace the existing Affordable Care Act, better known as “Obamacare”.

By contrast, European countries offer universal healthcare coverage to their citizens independent of their financial situation – something the United States’ government moved towards with Obamacare.

We asked the M3 Global Research panel if they think universal healthcare coverage, where everyone has access to quality health services and is protected against financial risk, should be available and mandated for everyone in the United States.

The survey was conducted amongst 2,895 M3 Global Research panel members in the USA. The results in the USA show that the majority (80%) agree that universal healthcare cover should be available and mandated for everyone in the United States.

USA_PatientsAugustMonthlyQuestion

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to give your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.

Overuse of unnecessary antibiotics

The overuse of unnecessary antibiotics has been the topic of the Monthly pulse we delivered to our panel members’ inboxes in July. In the UK it is estimated that 1.6 million unnecessary antibiotic prescriptions are issued each year and this issue is not exclusive to the UK.

Patients are used to visiting the GP whenever they suffer from illnesses like upper respiratory tract infections and often they expect to be prescribed antibiotic treatment, regardless of the efficacy.

Consequently, 70% of bacteria have now developed resistance to antibiotics as a result of overuse, which is now leading to the development of new strains of antibiotic-resistant bacteria.

We asked our community where the responsibility of raising awareness about antibiotic overuse lies – with the prescribing physician, or with healthcare institutions and/or governmental bodies?

The survey was conducted amongst 15,875 M3 members in Europe (Uk, France, Italy, Spain and Germany), Canada and USA.

The results in Canada, Europe and USA are similar. More than 90% in from the threes respondent groups agree that is the responsibility of the physician to reduce unnecessary antibiotic use.

In Europe, 93% of the healthcare professionals surveyed in the UK, Germany, France, Spain, and Italy think that it is the responsibility of the physician to reduce unnecessary antibiotic use. Spanish and Italian respondents, at 95%, are the most supportive of this view. Conversely, with 85% in favour, French doctors are the least supportive.

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to give your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.

overuse of unnecessary antibiotics

 

overuse of unnecessary antibiotics

AUGUST: Psoriasis Action Month

August is Psoriasis Action Month! How much do you know about psoriasis treatment options?

Capture

Psoriasis is a chronic, noncontagious immune-mediated disease that appears on the skin. It occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells.

It affects more than 8 million Americans. An estimated 125 million people worldwide live with psoriasis.

Plaque psoriasis is the most common form of the disease, affecting 80 percent of those with psoriasis. It appears as raised, red patches covered with a silvery white buildup of dead skin cells. Other types of psoriasis: o Guttate: Small dot-like lesions o Pustular: White blisters surrounded by red skin o Inverse: Appears as very red lesions in body folds, such as behind the knee, under the arm or in the groin o Erythrodermic: severe form of psoriasis that leads to widespread, fiery redness over most of the body. It can cause severe itching and pain, and make the skin come off in sheets.

Psoriasis can appear anywhere on the body, but most frequently occurs on the scalp, knees, elbows and torso. The exact cause of psoriasis is unknown. Genetics and external factors known as “triggers” play a role in the develop.

This August, the National Psoriasis Foundation (NPF) has developed new tools to help you take control of this disease. To start, test your knowledge on psoriasis treatment options!

Psoriasis Action Month

All quiz takers have the option to receive an NPF journaling kit. * Then, share this quiz with your colleagues and friends to increase awareness about Psoriasis Action Month and encourage others to take an active role in treating and managing the disease.

* Due to shipping costs, journaling kits are only available to residents of the U.S. and Canada. But anyone can get in touch with the NPF Patient Navigation Center to ask a question about their disease and learn more about treatment options!

All rights belong to the National Psoriasis Foundation (NPF). We would like to thank the National Psoriasis Foundation (NPF) for sharing with us their instructive quiz.